O3.2 * Phase I and dose ranging, phase II studies with...

Annals of Oncology 2015 / 03 Vol. 26; Iss. suppl 2

O3.2 * Phase I and dose ranging, phase II studies with IPH2201, a humanized monoclonal antibody targeting HLA-E receptor CD94/NKG2A

Seymour, L., Tinker, A., Hirte, H., Wagtmann, N., Dodion, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv081.2
Date:
March, 2015
File:
PDF, 28 KB
english, 2015
Conversion to is in progress
Conversion to is failed